Parenteral amygdalin was found to be ineffective in C57BL/6 mice with B16 melanoma and in AKR mice with BW5147 lymphatic leukemia, in doses ranging from 50 to 5000 mg/kg.

1

Supported in part by grants from the Institute of Medical Education and Research, St. Louis, Mo., and National Cancer Institute Grants 5 R10 15201 and 13053.

This content is only available via PDF.
©1976 American Association for Cancer Research.
1976
Cancer Research, Inc.